Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

ADC Therapeutics (ADCT) Assets: 2019-2023

Historic Assets for ADC Therapeutics (ADCT) over the last 3 years, with Sep 2023 value amounting to $466.9 million.

  • ADC Therapeutics' Assets fell 12.20% to $466.9 million in Q3 2023 from the same period last year, while for Sep 2023 it was $466.9 million, marking a year-over-year decrease of 12.20%. This contributed to the annual value of $490.9 million for FY2022, which is 79330.62% up from last year.
  • Latest data reveals that ADC Therapeutics reported Assets of $466.9 million as of Q3 2023, which was down 7.96% from $507.3 million recorded in Q2 2023.
  • ADC Therapeutics' 5-year Assets high stood at $638.0 million for Q3 2021, and its period low was $137,682 during Q4 2019.
  • Its 3-year average for Assets is $466.5 million, with a median of $490.9 million in 2022.
  • As far as peak fluctuations go, ADC Therapeutics' Assets surged by 124,119.86% in 2021, and later dropped by 19.63% in 2023.
  • ADC Therapeutics' Assets (Quarterly) stood at $137,682 in 2019, then reached $521,526 in 2020, then soared by 122,229.28% to $617,972 in 2021, then spiked by 79,330.62% to $490.9 million in 2022, then declined by 12.20% to $466.9 million in 2023.
  • Its Assets stands at $466.9 million for Q3 2023, versus $507.3 million for Q2 2023 and $467.7 million for Q1 2023.